anipamil has been researched along with Calcinosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleckenstein, A; Fleckenstein-Grün, G; Frey, M; Zorn, J | 1 |
1 review(s) available for anipamil and Calcinosis
| Article | Year |
|---|---|
Antihypertensive, anticalcinotic, and antiarteriosclerotic properties of anipamil, a long-acting new derivative of verapamil.
Topics: Animals; Antihypertensive Agents; Arteriosclerosis; Calcinosis; Calcium Channel Blockers; Humans; Propylamines; Rats | 1989 |